Latest News

The FDA approves Naox Link, a groundbreaking in-ear EEG device, transforming brain monitoring and enhancing neurologic care for patients and pharmacists.

Long-term type 2 diabetes significantly increases cardiovascular disease risk, revealing potential biomarkers for early intervention and prevention strategies.

Explore how pharmacogenomics enhances opioid therapy for effective pain management, optimizing analgesia while minimizing risks of adverse effects.

The pivotal clinical trial supports the concomitant administration of tirzepatide and ixekizumab, which significantly improves outcomes for patients with psoriatic arthritis (PsA) and obesity.

Explore how combining BTK inhibitors with CAR T-cell therapy enhances treatment efficacy for B-cell malignancies while managing potential toxicities.

AI enhances 340B program management by optimizing data analysis, improving accuracy, and streamlining operations for better patient care and compliance.

Recent studies reveal that weight recovery in anorexia nervosa does not ensure muscle restoration, highlighting the need for comprehensive recovery strategies.

Study author Nina B. Masters, PhD, MPH, highlighted an increase since the pandemic in the rates of patients missing their dose of measles, mumps, and rubella (MMR) vaccination at age 2 years.

Study authors describe a framework to help patients with chronic kidney disease (CKD) change and adhere to diets.

A new dual-antibody therapy shows promise in treating extramedullary multiple myeloma, offering hope for patients with limited options.

New dietary guidelines emphasize higher protein intake, reduced added sugars, and avoidance of ultra-processed foods to combat chronic diseases.

The role of cancer-associated fibroblasts in non–small cell lung cancer (NSCLC) drug resistance highlights innovative strategies to enhance treatment efficacy.

Bepirovirsen shows promise as a groundbreaking treatment for chronic hepatitis B, achieving significant functional cure rates in recent phase 3 trials.

Pharmacists enhance migraine management by providing personalized care, navigating treatment options, and addressing comorbid conditions for better patient outcomes.

Discover how the new PREVENT equations enhance cardiovascular risk assessments, improving patient screenings and prevention strategies for diverse populations.

The vouchers are intended to speed up review times for drugs that could fill key unmet needs for Americans.

Surveys reveal significant misunderstandings among Americans about shared decision-making in childhood vaccinations, highlighting the need for better public education.

Explaining megestrol acetate's dual role in managing symptoms and enhancing treatment efficacy for estrogen receptor–positive breast cancer.

Patients with type 2 diabetes (T2D) who initiated statins experienced reductions in major cardiovascular disease (CVD) and mortality across a spectrum of predicted 10-year risk.

To effectively and safely taper benzodiazepines, withdrawal challenges must be addressed while promoting patient involvement.